Rationing antiretroviral therapy in Africa--treating too few, too late.
AffiliationMedical unit, Médecins sans Frontières, and School of Public Health and Family Medicine, University of Cape Town, South Africa.
MetadataShow full item record
- Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
- Authors: Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr WM, Nash D, Abrams EJ, MTCT-Plus Initiative.
- Issue date: 2010 Feb 20
- HIV clinics are halting enrolment of new patients as funding stalls, MSF warns.
- Authors: Roehr B
- Issue date: 2009 Jul 20
- Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
- Authors: Rosso R, Nasi M, Di Biagio A, Repetto E, Dentone C, Pinti M, Nemes E, Ferraresi R, Mussini C, Esposito R, Viscoli C, Cossarizza A
- Issue date: 2008 Jan
- The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily.
- Authors: Tung MY, Mandalia S, Bower M, Gazzard B, Nelson M
- Issue date: 2005 May
- Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
- Authors: Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L
- Issue date: 2004 Dec 3